by admin | Apr 5, 2019 | Other
Insanitary Conditions in Compounding Pharmacies: The Regulatory Framework By Dylan Herr, Eagle Business Development Manager In the wake of the 2012 tragedy caused by contaminated drugs produced at the New England Compounding Center, Congress passed the Drug Quality...
by admin | Dec 4, 2018 | Other
by admin | Dec 4, 2018 | Other
The Compounder’s Crash Course to FDA and 503A Exemption Audits The Compounders’ Crash Course to FDA and 503A Exemption Audits Hosted by Eagle Analytical Services If your pharmacy were inspected by the FDA, would you be prepared? Protect your business. Join...
by admin | Dec 4, 2018 | Other
What to Test – When to Test – Why to Test The United Stated Pharmacopeial (USP) Guidelines have identified specific testing requirements that must occur with compounded preparations. These guidelines, which are based in science, were established to ensure patient care...
by admin | Mar 4, 2018 | Other
Environmental Monitoring Analyses: Early Warning Opportunities for Sterile Compounders By Ross Caputo Ph.D, Eagle President & CEO Environmental monitoring is an important element of the quality assurance program at sterile compounding facilities. These facilities...
